New DHA derivatives and their use as medicaments

Details for Australian Patent Application No. 2006242914 (hide)

Owner Pronova BioPharma Norge AS

Inventors Kopecky, Jan; Bryhn, Morten; Holmeide, Anne Kristin

Agent Mallesons

Pub. Number AU-B-2006242914

PCT Pub. Number WO2006/117664

Priority 0501044-2 04.05.05 SE; 60/677,351 04.05.05 US; 60/677,350 04.05.05 US; 0501045-9 04.05.05 SE

Filing date 4 May 2006

Wipo publication date 9 November 2006

Acceptance publication date 2 February 2012

International Classifications

C11C 3/00 (2006.01) Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom

A61K 31/202 (2006.01)

A61K 31/232 (2006.01)

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07C 57/03 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

C07C 69/587 (2006.01) Esters of carboxylic acids

C07D 263/24 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/117664 Priority application(s): WO2006/117664

22 May 2008 Alteration of Name

  The name of the applicant has been altered to Pronova BioPharma Norge AS

2 February 2012 Application Accepted

  Published as AU-B-2006242914

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242920-2-amido-6-amino-8-oxopurine derivatives as Toll-Like receptor modulators for the treatment of cancer and viral infections, such as hepatitis C

2006242898-Method and apparatus for cutting